Lead – EITP M&a Delivery Service Leader

Global Healthcare Fraud Detection Market to reach $9.1 billion by 2030, driven by AI adoption and regulatory pressure. "According to BCC Research, the global healthcare fraud detection market is projected to grow from $4.4 billion in 2024 to $9.1 billion by 2030, at a CAGR of 12.7%, driven by rising healthcare fraud cases, advances in AI and analytics, expanding cloud-based solutions and increasing adoption across global healthcare systems." Boston, Aug. 03, 2026 (GLOBE NEWSWIRE) - The global healthcare fraud detection market is poised for substantial growth, expanding from $4.4 billion in 2024 to $9.1 billion by 2030, representing a compound annual growth rate of 12.7%, according to a new report from BCC Research titled Global Healthcare Fraud Detection Market. BCC Research is a leading provider of market intelligence and advisory services for emerging technology markets. Key Findings * Market expansion accelerating: The healthcare fraud detection market will more than double over the forecast period, driven by escalating fraud losses and intensifying regulatory enforcement across global healthcare systems * North America dominates: The region commands 46.8% of the global market, reflecting advanced healthcare digitization, stringent regulatory frameworks, and sophisticated fraud detection infrastructure * AI transformation: Accelerated adoption of artificial intelligence, machine learning, and predictive analytics technologies is revolutionizing fraud detection capabilities, enabling real-time monitoring and prevention * Digital infrastructure boom: Widespread implementation of electronic health records and digital claims processing systems is creating vast datasets that power advanced fraud detection algorithms * Emerging market opportunity: Growing digitization of healthcare systems and expansion of insurance coverage in developing markets presents significant growth potential for fraud detection vendors * Competitive landscape consolidation: Established technology leaders including McKesson Corp., IBM Corp., SAS Institute Inc., and Optum Inc. are competing alongside specialized providers like FICO and emerging cloud-native platforms Market Drivers The healthcare fraud detection market is experiencing unprecedented growth driven by the mounting economic impact of healthcare fraud, which costs the industry hundreds of billions annually. Regulatory bodies worldwide are implementing stricter oversight and enforcement mechanisms, compelling healthcare organizations and insurers to invest heavily in sophisticated detection systems. The convergence of artificial intelligence and healthcare digitization is creating a perfect storm for market expansion, as AI-powered systems can analyze vast datasets in real-time to identify suspicious patterns and anomalies that traditional rule-based systems might miss. The shift toward value-based care models and increased transparency requirements are further amplifying demand for comprehensive fraud detection solutions. As healthcare systems become increasingly digital and interconnected, the attack surface for fraudulent activities expands, necessitating more advanced and integrated detection capabilities. Investment Considerations The healthcare fraud detection market presents compelling investment opportunities, particularly for companies developing AI-driven platforms and cloud-based solutions that can scale rapidly across different healthcare ecosystems. The market's defensive characteristics-driven by regulatory compliance rather than discretionary spending-provide resilience during economic downturns. However, investors should consider data privacy regulations and integration complexities as potential headwinds that could slow adoption. Companies with strong partnerships in the healthcare ecosystem and proven regulatory compliance track records, such as Optum and McKesson, appear best positioned to capture market share, while pure-play technology providers like FICO offer more concentrated exposure to the fraud detection opportunity. About the Report The report provides comprehensive market sizing, detailed segmentation analysis, competitive intelligence, and strategic forecasts for the global healthcare fraud detection market through 2030. Global Healthcare Fraud Detection Market includes in-depth analysis of technology trends, regulatory impacts, and investment opportunities across all major geographic regions. About BCC Research BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth trends, identify and evaluate new and changing market opportunities, and provide critical information and innovative decision support tools to help inform the strategic decision-making process. For media inquiries, email [email protected] or visit our media page for access to our market research library. Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. BCC Research LLC 50 Milk St., Ste. 16, Boston, MA 02109 [email protected] | +1 781-489-7301 www.bccresearch.com Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

McKesson Corporation announced a quarterly dividend of $0.94 per share, payable on 1 October 2026 to shareholders of record as of 1 September 2026. The healthcare distributor recently increased its share repurchase authorisation by $5 billion, signalling management confidence in the company's earnings power. McKesson's investment case centres on its position as a scale healthcare distributor benefiting from growing drug demand, whilst managing tight margins and regulatory pressure. The company projects $499.3 billion in revenue and $6.1 billion in earnings by 2029, requiring 7.4% annual revenue growth. Simply Wall St community members estimate McKesson's fair value between $827.49 and $2,283.03 per share. The company continues focusing on capital allocation whilst investing in automation and analytics to improve efficiency in the pharmaceutical supply chain.

RH strengthens leadership team with 2 appointments. Thomas Lester// Retail Editor//July 23, 2026 Corte Madera, Calif. - Upscale home furnishings retailer RH announced a pair of appointments to its senior leadership team. In her new role, Pilon will lead the company's gallery, hospitality, interior design, trade, contract, delight, people and optimization teams across every touchpoint of the Corte Madera, Calif.-based retailer's brand globally. Pilon has been with RH for 18 years and has held key leadership positions across the organization, including field leader of its Northern and Southern California galleries, senior vice president of delight and customer service operations, and most recently served as the company's chief people officer. "Over the past 18 years Sandy has been an important partner and leader of RH's transformation into the leading luxury home brand in the world," said Gary Friedman, chairman and CEO. "Her exceptional leadership and passionate advocacy of our values and beliefs give me great confidence in Sandy's ability to build and lead a team capable of building one of the most admired brands in the world." "I am deeply grateful for the trust Gary and our leadership team have placed in me," Pilon said. "Having spent the last 18 years growing alongside this extraordinary organization, it is an incredible honor to step into this role. I believe the greatest luxury we can offer is an exceptional experience - one that reflects our values in every interaction, inspires our people to do their life's best work, and creates lasting relationships with teams and customers around the world. I couldn't be more excited for what we will build." As chief legal and compliance officer, Hassanein will oversee all areas of the company's legal and compliance functions, including product safety and vendor compliance. He will report to Friedman. Prior to joining RH, Hassanein spent more than 10 years at McKesson Corp., one of the largest healthcare companies in the world, where he was a member of the chief legal officer's leadership team with responsibilities spanning a wide range of areas, including litigation, regulatory, compliance, government relations, supply chain and technology. "We are thrilled to welcome Ryan to Team RH," Friedman said. "Ryan's leadership experience extends well beyond the traditional scope of a legal role based on the range of his contributions at McKesson, one of the largest and most sophisticated companies in the world from a legal and compliance perspective. We believe Ryan is an outstanding addition to our executive leadership team as we continue to optimize our business as part of our growth and international expansion." Added Hassanein, "I am honored to join Gary and Team RH in the quest to build one of the most admired brands in the world and excited to participate in such an extraordinary effort. I look forward to making a meaningful contribution as RH continues to scale its business and strengthen its operational capabilities."